E. Keith Owens, Director
Calling upon more than 40 years of senior executive experience in the healthcare and insurance industries, Mr. Owens founded Brookside Institute in 2002, after several years of conducting extensive research of substance and alcohol abuse treatment centers throughout the United States. Mr. Owens studied the history, operations, development and regulations of opiate treatment centers for ten years. During this time, he studied the work of Dr. Joseph Volpicelli of the University of Pennsylvania; the Beck Institute; Dr. Richard Rawson of the University of California Los Angeles; Dr. Daniel Amen and his study of brain functions through SPECT scans; along with the pharmacological work in addiction with several pharmaceutical companies. Mr. Owens developed and refined Brookside Institute's innovative protocol, creating a science-based medical model using Naltrexone, Cognitive Behavioral Therapy, Brain Wave Analysis, Medication Management and Adjunctive Therapies.

Thom Montgomery, Ph.D., Research Consultant
Dr. Montgomery brings more than 25 years of experience to Brookside Institute as a certified specialist in the treatment of substance abuse. He has established protocols for various programs and has been associated with a variety of institutions including the American Public Health Foundation in Orange County, Martin Luther King Hospital in Anaheim, Twin Town Treatment Centers and San Pedro Peninsula Hospital.

Max Schneider, MD, CADC, FASM, Medical Consultant
Dr. Schneider is a highly respected medical expert who brings more than 50 years of experience to Brookside Institute as a medical consultant. He served on the Food and Drug Administration as Chair of the Drug Abuse Advisory Committee and has been a distinguished board and faculty member at the University of California Irvine, as well as various other medical associations. Dr. Schneider has also been a medical expert witness in more that 190 Superior court cases and is a well-known author who has appeared in many educational films regarding substance abuse. He has received countless awards for service and is listed in the 2001 Who's Who in America.

Percy Menzies, M. Pharm., Consulting Pharmacologist
Mr. Menzies worked for more that 18 years at DuPont Pharmaceuticals, as an Associate Product Manager, where he was responsible for Naltrexone. His interest in the pharmacological treatment of substance abuse dates back to the early 1980's, when an early version of a science-based medical model treatment using Naltrexone was first introduced. Mr. Menzies currently works with drug courts and other private and state agencies, to promote, train and evaluate the effectiveness of pharmacological treatments of substance abuse and alcoholism. He is regarded as one of the leading experts in this field and has spoken to a wide range of audiences in the United States and abroad on this subject.

Kim O'Donnell, C.A.T.C., Managing Director and Admissions
Trained in the organization and implementation of residential facilities, Ms. O'Donnell has worked within the various academic and community recovery systems such as: Behavioral Modification, Social Model and now Medical Model. A graduate of Saddleback College, with certificates as a Drug and Alcohol counselor, Family Mediation and Prevention Educator, Ms. O'Donnell has served as an educator in helping to improve community attitudes toward addiction. Working with individuals and groups in changing lifestyles, Ms. O'Donnell brings strength and clarity to her position, and is recognized as a leader in primary recovery and aftercare techniques.

Stephanie Laurent, International Marketing, Managing Director
Stephanie joined the Brookside staff after deciding to make a career change that included her lifelong dream of working in the field of Substance Abuse and Recovery. Her experience in Marketing and Public Relations, and her primary goal of helping people was what started her career at Brookside Institute in the role of Intake and Admissions, where she served from 2005-2007. Stephanie's current focus as International Marketing Director is to educate individuals about Brookside Institute's comprehensive medical approach to treat those suffering from addictive and mental health disorders. She is listed in the 2006-2007 Cambridge Who's Who. "I am honored and blessed to work with our caring staff, and inspired by all they do to change the lives of every individual who walks through our doors."